# Nucleotide asymmetry and flexible linker dynamics modulate drug efflux cycle of P-glycoprotein, A computational study

**Authors:** Sungho B. Han, Jim Warwicker, Hao Fan, Stephen M. Prince

PMC · DOI: 10.1016/j.csbj.2025.10.064 · Computational and Structural Biotechnology Journal · 2025-10-31

## TL;DR

This study uses computational methods to uncover how nucleotide asymmetry and flexible linker dynamics influence the drug efflux cycle of P-glycoprotein, a key player in multidrug resistance in cancer.

## Contribution

The study reveals the dynamic roles of nucleotide asymmetry and linker flexibility in modulating P-glycoprotein's drug efflux mechanism.

## Key findings

- Asymmetric nucleotide coordination at NBS correlates with TMD restructuring for substrate efflux.
- The flexible linker transiently forms α-helices that affect NBD dimerization.
- Conformation-dependent substrate pathways and TMD-linker interactions facilitate tunnel formation for drug transport.

## Abstract

Despite advancements in oncology, multidrug resistance (MDR) mediated by P-glycoprotein (P-gp/ABCB1) remains a major barrier to chemotherapy. P-gp is an ATP-binding cassette transporter that undergoes nucleotide-driven structural rearrangements to efflux chemotherapeutics, but the mechanistic details of the substrate transport remain poorly resolved. Here, we performed high-throughput multi-replica molecular dynamics to simulate P-gp in a lipid bilayer (totaling ∼110 µs) to dissect nucleotide-dependent conformational changes across the transport cycle. Our adaptive sampling strategy reveals asymmetric nucleotide coordination at nucleotide-binding sites (NBS), which correlates with transmembrane domain (TMD) restructuring for substrate efflux. The experimentally unresolved flexible linker transiently forms up to five turns of α-helix that affects the nucleotide binding domain (NBD) dimerization process. We identified conformation-dependent substrate/allocrite pathways including nucleotide-specific access routes, while TMD-linker interaction facilitates substrate access tunnel formation. Together, these pathways reveal that the concerted interplay of nucleotide occupancy, linker dynamics, and overall protein conformation governs the structural plasticity and broad substrate promiscuity of the substrate binding cavity in P-gp. By integrating these findings, this work bridges static structural data with dynamic functional insights to further our understanding of the P-gp substrate translocation cycle.

## Linked entities

- **Genes:** ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243]
- **Proteins:** Mdr65 (Multi drug resistance 65), PGP (phosphoglycolate phosphatase)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** PGP (phosphoglycolate phosphatase) [NCBI Gene 283871] {aka AUM, G3PP, PGPase}, ABCA4 (ATP binding cassette subfamily A member 4) [NCBI Gene 24] {aka ABC10, ABCR, ARMD2, CORD3, FFM, RMP}, ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}
- **Diseases:** MDR (MESH:D018088)
- **Chemicals:** lipid (MESH:D008055), Nucleotide (MESH:D009711)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12636386/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12636386/full.md

## References

73 references — full list in the complete paper: https://tomesphere.com/paper/PMC12636386/full.md

---
Source: https://tomesphere.com/paper/PMC12636386